Major depressive disorder (MDD) often begins during adolescence, a critical stage of physical and emotional development. While its symptoms are well recognised, doctors still largely rely on interviews and self-reported questionnaires to diagnose the condition. A new study from China now suggests that changes in gut bacteria and blood-based inflammation markers could help identify depression in teenagers more accurately.
Researchers from the Chongqing Medical University and other institutes have identified specific gut microbiota patterns associated with adolescent depression. Their findings were published in the peer-reviewed journal Translational Psychiatry.
Study focuses on first-episode adolescent depression
The research involved 46 adolescents under the age of 19 experiencing their first episode of MDD, along with 44 healthy teenagers of similar age and sex. None of the participants with depression had received medication prior to the study.
Scientists analysed blood and stool samples to examine inflammation markers, gut barrier proteins, and the composition of gut bacteria. Blood tests showed higher levels of inflammatory markers such as IL-6, IL-8, TNF-α and CRP in adolescents with depression, alongside proteins indicating weakened gut barriers.
At the same time, stool analysis revealed clear differences in gut bacteria. Teenagers with MDD showed reduced microbial balance and altered ratios of key bacterial groups. Certain bacteria, including Intestinimonas and Barnesiella, were more abundant, while Dialister and Collinsella were significantly reduced.
Gut–brain connection offers diagnostic promise
The researchers found that combining gut bacteria data with blood-based inflammation markers could identify depression with high accuracy. In particular, changes involving Collinsella and gut barrier proteins showed strong diagnostic potential.
The study also highlighted the role of short-chain fatty acids (SCFAs), which are produced when gut bacteria break down dietary fibre. These molecules influence gut barrier function and inflammation, both of which may play a role in the development of depressive symptoms.
Towards earlier and more objective diagnosis
Experts say the findings strengthen evidence of the gut–brain axis, especially during adolescence when both the brain and digestive system are still developing.
The researchers believe these biomarkers could eventually support earlier and more objective diagnosis of depression in young people, complementing clinical assessments rather than replacing them.
They also suggest that future treatments may explore ways to improve mental health by restoring gut balance through diet, probiotics, or targeted therapies.
While further large-scale studies are needed, the research offers hope for better detection and personalised care for adolescents living with depression